These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 1908444)

  • 1. Pharmacokinetics of 2',3'-dideoxyadenosine in dogs.
    Wientjes MG; Placke ME; Chang MJ; Page JG; Kluwe WM; Tomaszewski JE
    Invest New Drugs; 1991 May; 9(2):159-68. PubMed ID: 1908444
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhancement of the anti-HIV-1 activity of ddAdo by coformycin, EHNA and deaza-EHNA derivatives.
    Marongiu ME; Pani A; Tinti E; Grifantini M; Franchetti P; Cristalli G; La Colla P
    New Microbiol; 1995 Oct; 18(4):359-70. PubMed ID: 8590388
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibitors of IMP dehydrogenase stimulate the phosphorylation of the anti-human immunodeficiency virus nucleosides 2',3'-dideoxyadenosine and 2',3'-dideoxyinosine.
    Hartman NR; Ahluwalia GS; Cooney DA; Mitsuya H; Kageyama S; Fridland A; Broder S; Johns DG
    Mol Pharmacol; 1991 Jul; 40(1):118-24. PubMed ID: 1677450
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolic pathways for the activation of the antiretroviral agent 2',3'-dideoxyadenosine in human lymphoid cells.
    Johnson MA; Ahluwalia G; Connelly MC; Cooney DA; Broder S; Johns DG; Fridland A
    J Biol Chem; 1988 Oct; 263(30):15354-7. PubMed ID: 3262616
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhancement by 2'-deoxycoformycin of the 5'-phosphorylation and anti-human immunodeficiency virus activity of 2',3'-dideoxyadenosine and 2'-beta-fluoro-2',3'-dideoxyadenosine.
    Ahluwalia GS; Cooney DA; Shirasaka T; Mitsuya H; Driscoll JS; Johns DG
    Mol Pharmacol; 1994 Nov; 46(5):1002-8. PubMed ID: 7969062
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anomalous accumulation and decay of 2',3'-dideoxyadenosine-5'-triphosphate in human T-cell cultures exposed to the anti-HIV drug 2',3'-dideoxyinosine.
    Ahluwalia G; Cooney DA; Hartman NR; Mitsuya H; Yarchoan R; Fridland A; Broder S; Johns DG
    Drug Metab Dispos; 1993; 21(2):369-76. PubMed ID: 8097711
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics of 2',3'-dideoxyadenosine and 2',3'-dideoxyinosine in patients with severe human immunodeficiency virus infection.
    Hartman NR; Yarchoan R; Pluda JM; Thomas RV; Marczyk KS; Broder S; Johns DG
    Clin Pharmacol Ther; 1990 May; 47(5):647-54. PubMed ID: 2111751
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 2'-Fluoro-2',3'-dideoxyarabinosyladenine: a metabolically stable analogue of the antiretroviral agent 2',3'-dideoxyadenosine.
    Masood R; Ahluwalia GS; Cooney DA; Fridland A; Marquez VE; Driscoll JS; Hao Z; Mitsuya H; Perno CF; Broder S
    Mol Pharmacol; 1990 Apr; 37(4):590-6. PubMed ID: 2109183
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-performance liquid chromatographic analysis of 2'-fluoro-2',3'-dideoxyadenosine and 2'-fluoro-2',3'-dideoxyinosine in dog plasma and urine.
    Campbell DA; Shah VR; Srinivas NR; Shyu WC
    J Pharm Sci; 1996 Aug; 85(8):890-2. PubMed ID: 8863284
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of altered metabolism in dideoxynucleoside pharmacokinetics. Studies of 2'-beta-fluoro-2',3'-dideoxyinosine and 2'-beta-fluoro-2',3'-dideoxyadenosine in rats.
    Singhal D; Morgan ME; Anderson BD
    Drug Metab Dispos; 1996 Oct; 24(10):1155-61. PubMed ID: 8894519
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Permeation and salvage of dideoxyadenosine in mammalian cells.
    Plagemann PG; Woffendin C
    Mol Pharmacol; 1989 Jul; 36(1):185-92. PubMed ID: 2787472
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of brain tissue localized purine metabolizing enzymes in the central nervous system delivery of anti-HIV agents 2'-beta-fluoro-2',3'-dideoxyinosine and 2'-beta-fluoro-2',3'-dideoxyadenosine in rats.
    Singhal D; Morgan ME; Anderson BD
    Pharm Res; 1997 Jun; 14(6):786-92. PubMed ID: 9210198
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Single dose and multiple dose pharmacokinetics of 2'-fluoro-2',3'-dideoxyadenosine and 2'-fluoro-2',3'-dideoxyinosine, anti-HIV agents, in rats.
    Srinivas NR; Shyu WC
    Eur J Drug Metab Pharmacokinet; 1999; 24(4):329-34. PubMed ID: 10892896
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Absorption, disposition, and metabolism of [14C]didanosine in the beagle dog.
    Kaul S; Shyu WC; Shukla UA; Dandekar KA; Barbhaiya RH
    Drug Metab Dispos; 1993; 21(3):447-53. PubMed ID: 8100500
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 2'-beta-fluoro-2',3'-dideoxyadenosine, lodenosine, in rhesus monkeys: plasma and cerebrospinal fluid pharmacokinetics and urinary disposition.
    Roth JS; McCully CM; Balis FM; Poplack DG; Kelley JA
    Drug Metab Dispos; 1999 Oct; 27(10):1128-32. PubMed ID: 10497138
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhancement by hydroxyurea of the anti-human immunodeficiency virus type 1 potency of 2'-beta-fluoro-2',3'-dideoxyadenosine in peripheral blood mononuclear cells.
    Gao WY; Mitsuya H; Driscoll JS; Johns DG
    Biochem Pharmacol; 1995 Jul; 50(2):274-6. PubMed ID: 7632173
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Disposition of 2',3'-dideoxyadenosine and 2',3'-dideoxyinosine in mice.
    el Dareer SM; Tillery KF; Kalin JR; Hill DL
    Invest New Drugs; 1989 Jul; 7(2-3):139-46. PubMed ID: 2507472
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhanced stimulation by ribavirin of the 5'-phosphorylation and anti-human immunodeficiency virus activity of purine 2'-beta-fluoro-2',3'-dideoxynucleosides.
    Johns DG; Ahluwalia GS; Cooney DA; Mitsuya H; Driscoll JS
    Mol Pharmacol; 1993 Sep; 44(3):519-23. PubMed ID: 8371712
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics of didanosine in patients with acquired immunodeficiency syndrome or acquired immunodeficiency syndrome-related complex.
    Knupp CA; Shyu WC; Dolin R; Valentine FT; McLaren C; Martin RR; Pittman KA; Barbhaiya RH
    Clin Pharmacol Ther; 1991 May; 49(5):523-35. PubMed ID: 1903100
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics of 2',3'-dideoxyinosine (BMY-40900), a new anti-human immunodeficiency virus agent, after administration of single intravenous doses to beagle dogs.
    Kaul S; Knupp CA; Dandekar KA; Pittman KA; Barbhaiya RH
    Antimicrob Agents Chemother; 1991 Apr; 35(4):610-4. PubMed ID: 1906259
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.